Randalj Kirk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Precigen (NASDAQ:PGEN) Earns Buy Rating from HC Wainwright

Precigen (NASDAQ:PGEN) Earns Buy Rating from HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesRandalj kirkBlackrock incPatient capital managementPrecigen company profilePrecigen incRenaissance technologiesMillennium managementAmerica corpFree reportDirector randalCapital managementGet free reportPrecigen daily

Precigen (NASDAQ:PGEN) Stock Rating Reaffirmed by JMP Securities

Precigen (NASDAQ:PGEN) Stock Rating Reaffirmed by JMP Securities
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Randalj kirkSecurities exchange commissionPrecigen incNuveen asset managementPrecigen company profileGroup plcCitigroup incSg americas securitiesFree reportTrading downDirector randalExchange commissionGeneral group plcAsset managementGet free reportPrecigen daily

Precigen (NASDAQ:PGEN) Receives Buy Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a $6.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Precigen’s Q1 2024 earnings at ($0.09) EPS, Q2 2024 earnings at ($0.09) EPS, […]

United statesRandalj kirkFisher asset managementSigma securitiesPrecigen incCresset asset managementPrecigen company profileSecurities exchange commissionChina universal asset management coFree reportDirector randalExchange commissionAsset managementEmployees retirement systemChina universal asset managementUniversal asset management

Precigen s (PGEN) Buy Rating Reiterated at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a report issued on Wednesday, Benzinga reports. HC Wainwright currently has a $6.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Precigen’s Q1 2024 earnings at ($0.09) EPS, Q2 2024 earnings at ($0.09) EPS, Q3 […]

Randalj kirkBlackrock incPrecigen incPatient capital managementGeode capital managementVanguard group incFree reportDirector randalCapital managementState street corpStreet corpGet free reportPrecigen dailyNasdaq pgenReiterated ratingHc wainwright

StockNews com Upgrades Precigen (NASDAQ:PGEN) to Sell

Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research note issued on Tuesday. Precigen Stock Performance NASDAQ PGEN opened at $1.38 on Tuesday. The company’s fifty day moving average is $1.30 and its two-hundred day moving average is $1.32. Precigen has a 52-week low […]

United statesRandalj kirkPrincipal financial group incPrecigen incSg americas securitiesMagnolia capital advisorsSanders morris harrisAllspring global investments holdingsPrecigen company profileSecurities exchange commissionGet free reportDirector randalExchange commissionMorris harrisGlobal investments holdingsFinancial group